Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hazel Webb

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
The Lancet. Child & Adolescent Health|October 22, 2018
Management of steroid-resistant nephrotic syndrome in children and adolescentsKjell Tullus, Hazel Webb, Arvind Bagga
Archives of Disease in Childhood|November 12, 2020
Rituximab in childhood steroid-sensitive nephrotic syndrome: are multiple subsequent courses safe and effective?Chantida Subun, Picha Suwannahitatorn, Hazel Webb, et al.
Pediatric Nephrology (Berlin, Germany)|September 29, 2016
Use of a low-dose prednisolone regimen to treat a relapse of steroid-sensitive nephrotic syndrome in childrenKarnika Raja, Ami Parikh, Hazel Webb, et al.
Pediatric Nephrology (Berlin, Germany)|November 12, 2021
Long-term obesity prevalence and linear growth in children with idiopathic nephrotic syndrome: is normal growth and weight control possible with steroid-sparing drugs and low-dose steroids for relapses?Nilüfer Göknar, Hazel Webb, Aoife Waters, et al.
Pediatric Nephrology (Berlin, Germany)|September 7, 2021
The effect of levamisole on kidney function in children with steroid-sensitive nephrotic syndromeLieke A Hoogenboom, Hazel Webb, Kjell Tullus, et al.
Pediatric Nephrology (Berlin, Germany)|November 4, 2015
Cyclophosphamide and rituximab in frequently relapsing/steroid-dependent nephrotic syndromeHazel Webb, Graciana Jaureguiberry, Stephanie Dufek, et al.
Pediatric Nephrology (Berlin, Germany)|July 8, 2022
Mendelian steroid resistant nephrotic syndrome in childhood: is it as common as reported?Zainab Arslan, Hazel Webb, Emma Ashton, et al.
European Journal of Human Genetics : EJHG|May 30, 2020
Genetic aspects of congenital nephrotic syndrome: a consensus statement from the ERKNet-ESPN inherited glomerulopathy working groupBeata Stefania Lipska-Ziętkiewicz, Fatih Ozaltin, Tuula Hölttä, et al.
Nature Reviews. Nephrology|January 30, 2021
Management of congenital nephrotic syndrome: consensus recommendations of the ERKNet-ESPN Working GroupOlivia Boyer, Franz Schaefer, Dieter Haffner, et al.
Kidney International|December 26, 2019
Both the rituximab dose and maintenance immunosuppression in steroid-dependent/frequently-relapsing nephrotic syndrome have important effects on outcomesEugene Yu-Hin Chan, Hazel Webb, Ellen Yu, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
The Lancet. Child & Adolescent Health|October 22, 2018
Management of steroid-resistant nephrotic syndrome in children and adolescentsKjell Tullus, Hazel Webb, Arvind Bagga
Archives of Disease in Childhood|November 12, 2020
Rituximab in childhood steroid-sensitive nephrotic syndrome: are multiple subsequent courses safe and effective?Chantida Subun, Picha Suwannahitatorn, Hazel Webb, et al.
Pediatric Nephrology (Berlin, Germany)|September 29, 2016
Use of a low-dose prednisolone regimen to treat a relapse of steroid-sensitive nephrotic syndrome in childrenKarnika Raja, Ami Parikh, Hazel Webb, et al.
Pediatric Nephrology (Berlin, Germany)|November 12, 2021
Long-term obesity prevalence and linear growth in children with idiopathic nephrotic syndrome: is normal growth and weight control possible with steroid-sparing drugs and low-dose steroids for relapses?Nilüfer Göknar, Hazel Webb, Aoife Waters, et al.
Pediatric Nephrology (Berlin, Germany)|September 7, 2021
The effect of levamisole on kidney function in children with steroid-sensitive nephrotic syndromeLieke A Hoogenboom, Hazel Webb, Kjell Tullus, et al.
Pediatric Nephrology (Berlin, Germany)|November 4, 2015
Cyclophosphamide and rituximab in frequently relapsing/steroid-dependent nephrotic syndromeHazel Webb, Graciana Jaureguiberry, Stephanie Dufek, et al.
Pediatric Nephrology (Berlin, Germany)|July 8, 2022
Mendelian steroid resistant nephrotic syndrome in childhood: is it as common as reported?Zainab Arslan, Hazel Webb, Emma Ashton, et al.
European Journal of Human Genetics : EJHG|May 30, 2020
Genetic aspects of congenital nephrotic syndrome: a consensus statement from the ERKNet-ESPN inherited glomerulopathy working groupBeata Stefania Lipska-Ziętkiewicz, Fatih Ozaltin, Tuula Hölttä, et al.
Nature Reviews. Nephrology|January 30, 2021
Management of congenital nephrotic syndrome: consensus recommendations of the ERKNet-ESPN Working GroupOlivia Boyer, Franz Schaefer, Dieter Haffner, et al.
Kidney International|December 26, 2019
Both the rituximab dose and maintenance immunosuppression in steroid-dependent/frequently-relapsing nephrotic syndrome have important effects on outcomesEugene Yu-Hin Chan, Hazel Webb, Ellen Yu, et al.
Pageof 2